However, semaglutide has more clinical trial data and has shown benefits in treating various conditions like heart disease, kidney disease, and liver disease, sometimes independently of its effects on weight or glucose
Migraine: Epidemiology, Burden, and Comorbidity
They also affect hunger and digestion
The goal is to help patients use GLP-1 therapy safely and effectively with medical supervision
BCBSs monthly spending on GLP-1s in its client small group segment has more than tripled since the beginning of 2023
If you are seeking weight loss and are interested in using GLP-1s, be sure to have additional support for behavior and lifestyle change. Theres no denying that GLP-1s have been game-changing for many Americans struggling with weight